Oxford and AstraZeneca resume coronavirus vaccine trial
Published
Regulator allows testing to continue after investigation of possible side-effect in one participant
Full ArticlePublished
Regulator allows testing to continue after investigation of possible side-effect in one participant
Full ArticleAstraZeneca is still waiting for the U.S. drug regulator to approve the restart of the clinical trial of its potential COVID-19..
Watch VideoA coronavirus vaccine trial in the U.S. is still on hold.
AstraZeneca released its trial blueprint Saturday..